Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Clinical Pharmacy and Pharmacology | JAMA – JAMA Network October 5, 2023
What to know about the new bivalent COVID-19 booster and how to get it in Athens | City News December 3, 2022December 3, 2022
A new weight-loss drug could be an obesity game-changer for Louisiana. But what will it cost? | Health care/Hospitals June 19, 2022June 19, 2022